Overview
- BNB Plus said it has initial commitments for $4.1 million in Series B‑1 and B‑2 convertible preferred stock and is targeting $5 million in total proceeds.
- The company expects the financing to raise its cash and digital-asset holdings to more than $16.4 million based on its disclosed valuations.
- Lead investors include Comstock Multichain Fund and other crypto-focused backers such as Off the Chain LP, and GlobalStake Infrastructure will help lead the strategic review.
- Series B‑1 preferreds are priced at $1.05 per share with an 8% annual dividend, a 1.5x liquidation preference and multi‑year warrants while Series B‑2 is priced at $0.38 per share, giving new holders senior claims over common stock.
- Management ties the raise to exploring AI infrastructure opportunities and says the financing signals investor confidence after cost cuts and reported profitability at LineaRx, though specific AI plans remain undefined.